Skip to main content

Methods to Classify Bacterial Pathogens in Cystic Fibrosis

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 742))

Abstract

Many bacteria can be detected in CF sputum, pathogenic and commensal. Modified Koch’s criteria for identification of established and emerging CF pathogens are therefore described. Methods are described to isolate bacteria and to detect bacterial biofilms in sputum or lung tissue from CF patients by means of conventional culturing and staining techniques and by the PNA FISH technique. Additionally, the confocal scanning laser microscopy technique is described for studying biofilms in vitro in a flow cell system. The recA-gene PCR and the RFLP-based identification methods are described for identification of isolates from the Burkholderia complex to the species level. DNA typing by PFGE, which can be used for any bacterial pathogen, is described as it is employed for Pseudomonas aeruginosa. A commercially available ELISA method is described for measuring IgG antibodies against P. aeruginosa in CF patients.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Westh, J. B. (2001) Pulmonary Physiology and Pathophysiology. Lippincott Williams & Wilkins, Philadelphia, PA.

    Google Scholar 

  2. Boucher, R. C. (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23, 146–158.

    Article  PubMed  CAS  Google Scholar 

  3. Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., et al. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44, 547–558.

    Article  PubMed  Google Scholar 

  4. Høiby, N., and Frederiksen, B. (2000) Microbiology of cystic fibrosis, in (Hodson, M. E., and Geddes, D. M., eds.), Cystic Fibrosis, 9th ed. Arnold, London, pp. 83–107.

    Google Scholar 

  5. Wilson, M. (2005) Microbial Inhabitants of Humans. Cambridge, Cambridge University Press.

    Google Scholar 

  6. Høiby, N., and Pressler, T. (2006) Emerging pathogens in cystic fibrosis. Eur Respir Monog Cyst Fibros Eur Respir Soc 35, 66–78.

    Google Scholar 

  7. Skov, M., Koch, C., Reimert, C. M., and Poulsen, L. K. (2000) Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 55, 50–58.

    Article  PubMed  CAS  Google Scholar 

  8. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317–325.

    PubMed  CAS  Google Scholar 

  9. Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., et al. (2010) Polymorphonuclear leukocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65, 57–62.

    Article  PubMed  CAS  Google Scholar 

  10. Worlitzsch, D., Rintelen, C., Bohm, K., Wollschlager, B., Merkel, N., Borneff-Lipp, M., et al. (2009) Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 15, 454–460.

    Article  PubMed  CAS  Google Scholar 

  11. Koch, R. (1884) Die Aetiologie der Tuberkulose. Mittheil Kaiserl Gesundheitsamt 2, 1–88.

    Google Scholar 

  12. Taylor-Robinson, D. (1983) The role of M. genitalum in non-gonococcal urethritis: a review. Yale J Biol Med 56, 537–543.

    PubMed  CAS  Google Scholar 

  13. Høiby, N. (1974) Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B 82, 541–550.

    Google Scholar 

  14. Lee, T.W.R., Brownlee, K.G., Conway, S.P., Denton, M., and Littlewood, J.M. (2003) Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2, 29–34.

    Article  PubMed  Google Scholar 

  15. Proesmans, M., Balinska-Miskiewicz, W., Dupont, L., Bossuyt, X., Verhaegen, J., Høiby, N., et al. (2006) Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis center. Eur Respir J 27, 937–943.

    PubMed  CAS  Google Scholar 

  16. Pressler, T., Karpati, F., Gramström, M., Knudsen, P.K., Lindblad, A., Hjelte, L., et al. (2009) Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 8, 37–42.

    Article  PubMed  CAS  Google Scholar 

  17. Döring, G., Buhl, V., Høiby, N., Schiøtz, P. O., and Botzenhart, K. (1984) Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients. Acta Pathol Microbiol Scand C 92, 307–312.

    Google Scholar 

  18. Høiby, N. (2002) Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros 1, 249–254.

    Article  PubMed  Google Scholar 

  19. Wainwright, C. E., Grimwood, K., Carlin, J. B., Vidmar, S., Cooper, P. J., Francis, P.W., et al. (2008) Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol 43, 965–972.

    Article  PubMed  Google Scholar 

  20. Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L., and Pfaller, M. A. (2007) Manual of Clinical Microbiology, 9th ed. ASM Press, Washington DC.

    Google Scholar 

  21. Diederen, B. M. W., van Leest, M. -L., van Duijin, I., Willemse, P., van Keulen, P. H. J., and Kluytmans, J. A. J. W. (2006) Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44, 586–588.

    Article  PubMed  CAS  Google Scholar 

  22. Levi, K., and Towner, K. J. (2003) Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. J Clin Microbiol 41, 3890–3892.

    Article  PubMed  CAS  Google Scholar 

  23. Hoffmann, N., Rasmussen, T. B., Jensen, P. Ø., Stub, C., Hentzer, M., Molin, S., et al. (2005) Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 73, 2504–2514.

    Article  PubMed  CAS  Google Scholar 

  24. Haussler, S., Ziegler, I., Lottel, A., von Gotz, F., Rohde, M., Wehmhohner, D., et al. (2003) Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52, 295–301.

    Article  PubMed  Google Scholar 

  25. Balke, B., Schmoldt, S., Haussler, S., Suerbaum, S., Heesemann, J., and Hogardt, M. (2008) A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis. J Cyst Fibros 7, 7–14.

    Article  PubMed  Google Scholar 

  26. Coenye, T., Vandamme, P., Govan, J. R. W., and Lipuma, J. J. (2001) Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427–3436.

    Article  PubMed  CAS  Google Scholar 

  27. Degand, N., Carbonelle, E., Dauphin, B., Beretti, J. -L., Bourgeois, M. L., Sermet.Gaudelus, I., et al. (2008) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46, 3361–3367.

    Google Scholar 

  28. Wellinghausen, N., Kothe, J., Wirths, B., Sigge, A., and Popperts, S. (2005) Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphological nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43, 4070–4075.

    Article  PubMed  CAS  Google Scholar 

  29. Fluge, G., Ojeniyi, B., Høiby, N., Digranes, A., Ciofu, O., Hunstad, E., et al. (2001) Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect 7, 238–243.

    Article  PubMed  CAS  Google Scholar 

  30. Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N., et al. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infection. J Bact 190, 2767–2776.

    Article  PubMed  CAS  Google Scholar 

  31. Xu, J., Moore, J. E., Murphy, P. G., Millar, B. C., Redmond, A. O. B., and Elborn, J. S. (2004) Molecular (PCR) detection of Pseudomonas spp. other than P-aeruginosa directly from the sputum of adults and children with cystic fibrosis. Br J Biomed Sci 61, 147–149.

    PubMed  CAS  Google Scholar 

  32. Høiby, N. (1977) Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Path Microbiol Scand Suppl 262 C, 3–96.

    Google Scholar 

  33. Bjarnsholt, T., Kirketerp-Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., et al. (2008) Why chronic wounds won’t heal: a novel hypothesis. Wound Rep Regen 16, 2–10.

    Article  Google Scholar 

  34. Bjarnsholt, T., Tolker-Nielsen, T., Givskov, M., Janssen, M., and Christensen, L. H. (2009) Detection of bacteria by FISH in culture-negative soft tissue filler lesions. Dermatol Surg 35, 1620–1624.

    Article  PubMed  CAS  Google Scholar 

  35. Høiby, N., Johansen, H. K., Moser, C., Song, Z. J., Ciofu, O., and Kharazmi, A. (2001) Pseudomonas aeruginosa and the biofilm mode of growth. Microb Infect 3, 1–13.

    Article  Google Scholar 

  36. Donlan, R. M., and Costerton, J. W. (2002) Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–178.

    Article  PubMed  CAS  Google Scholar 

  37. Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., et al. (2005) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151, 373–383.

    Article  PubMed  CAS  Google Scholar 

  38. Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., and Stewart, P. S. (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47, 317–323.

    Article  PubMed  CAS  Google Scholar 

  39. O’Toole, G., Kaplan, H. B., and Kolter, R. (2000) Biofilm formation as microbial development. Ann Rev Microbiol 54, 49–79.

    Article  Google Scholar 

  40. Sauer, K. T. (2003) The genomics and proteomics of biofilm formation. Genome Biol 4, 219–229.

    Article  PubMed  Google Scholar 

  41. Hentzer, M., Eberl, L., and Givskov, M. (2005) Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2, 37–61.

    Article  Google Scholar 

  42. Purevdorj, B., Costerton, J. W., and Stoodley, P. (2002) Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl Env Microbiol 68, 4457–4464.

    Article  CAS  Google Scholar 

  43. Reimmann, C., Ginet, N., Michel, L., Keel, C., Michaux, P., Krishnapillai, V., et al. (2002) Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 148, 923–932.

    PubMed  CAS  Google Scholar 

  44. Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., and Davies, D. G. (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bact 184, 1140–1154.

    Article  PubMed  CAS  Google Scholar 

  45. Klausen, M., Aaes-Jorgensen, A., Molin, S., and TolkerNielsen, T. (2003) Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50, 61–68.

    Article  PubMed  CAS  Google Scholar 

  46. Hansen, C. R., Pressler, T., Nielsen, K. G., Jensen, P. Ø., Bjarnsholt, T., and Høiby, N. (2010) Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 9, 51–58.

    Article  PubMed  CAS  Google Scholar 

  47. Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J., Nielsen, A. T., Givskov, M., et al. (1999) Molecular tools for study of biofilm physiology. Biofilms 1, 20–42.

    Article  Google Scholar 

  48. Coenye, T., Mahenthiralingam, E., Henry, D., LiPuma, J. J., Laevens, S., Gillis, M., et al. (2001) Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 51, 1481–1490.

    Article  PubMed  CAS  Google Scholar 

  49. Mahenthiralingam, E., Bischof, J., Byrne, S. K., Radomski, C., Davies, J. E., AvGay, Y., et al. (2000) DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38, 3165–3173.

    PubMed  CAS  Google Scholar 

  50. Romling, U., and Tümmler, B. (2000) Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38, 464–465.

    PubMed  CAS  Google Scholar 

  51. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis. Criteria for bacterial strains typing. J Clin Microbiol 33, 2233–2239.

    PubMed  CAS  Google Scholar 

  52. Struelens, M. J. (1996) Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 2, 2–11.

    Article  PubMed  Google Scholar 

  53. Pressler, T., Frederiksen, B., Skov, M., Garred, P., Koch, C., and Høiby, N. (2006) Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection – a case control study. J Cyst Fibros 5, 9–15.

    Article  PubMed  CAS  Google Scholar 

  54. Ratjen, F., Walter, H., Haug, M., Meisner, C., Grasemann, H., and Döring, G. (2007) Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 42, 249–255.

    Article  PubMed  Google Scholar 

  55. Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., and Høiby, N. (2008) Spread of colistin-resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 7, 391–397.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Niels Høiby .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Bjarnsholt, T., Nielsen, X.C., Johansen, U., Nørgaard, L., Høiby, N. (2011). Methods to Classify Bacterial Pathogens in Cystic Fibrosis. In: Amaral, M., Kunzelmann, K. (eds) Cystic Fibrosis. Methods in Molecular Biology, vol 742. Humana Press. https://doi.org/10.1007/978-1-61779-120-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-120-8_9

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-119-2

  • Online ISBN: 978-1-61779-120-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics